Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K MAGUIREZEISS
Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?
Pharmacological Research
Pharmacology
Related publications
Correction: Targeting the Intrinsically Disordered Structural Ensemble of Α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
PLoS ONE
Multidisciplinary
Α-Synuclein and Anti-Α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
PLoS ONE
Multidisciplinary
Clearing Extracellular Alpha-Synuclein From Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
Brain Sciences
Neuroscience
Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on Α-Synuclein
Neuron
Neuroscience
Lack of Pathogenic Potential of Peripheral Α-Synuclein Aggregates From Parkinson’s Disease Patients
Acta neuropathologica communications
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Nigrostriatal Interaction in the Aging Brain: New Therapeutic Target for Parkinson’s Disease
Acta Neurobiologiae Experimentalis
Medicine
Neuroscience
Selective Α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson’s Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Role for Α-Synuclein in Axon Growth and Its Implications in Corticostriatal Glutamatergic Plasticity in Parkinson’s Disease
Molecular Neurodegeneration
Molecular Neuroscience
Neurology
Molecular Biology
Cellular
The Cell-Death-Associated Polymer PAR Feeds Forward Α-Synuclein Toxicity in Parkinson’s Disease
Molecular Cell
Cell Biology
Molecular Biology
